MedTrace Logo

The Effect on Envelope of Motion in Asymptomatic Bruxers

NCT05604729 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-05-03

No results posted yet for this study

Summary

Investigating the effect of botulinum neurotoxin on the jaw-neck envelope of motion.

Conditions

  • Tooth Wear
  • Bruxism

Interventions

DRUG

Botulinum toxin type A

Botulinum Neurotoxin type A

DRUG

Placebo

Saline solution

Sponsors & Collaborators

  • Umeå University

    collaborator OTHER

  • Region Västerbotten

    lead OTHER_GOV

Principal Investigators

  • Mattias Pettersson, PhD · Umeå University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2024-12-31
Completion
2025-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05604729 on ClinicalTrials.gov